SNS Financial Group’s Anavex Life Sciences AVXL Stock Holding History

SNS Financial Group’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-20,000	Closed	-$186K	–	190
2023 Q4	$186K	Hold	20,000	–	–	0.02%	181
2023 Q3	$131K	Hold	20,000	–	–	0.02%	174
2023 Q2	$163K	Hold	20,000	–	–	0.02%	178
2023 Q1	$171K	Hold	20,000	–	–	0.02%	175
2022 Q4	$185K	Hold	20,000	–	–	0.03%	186
2022 Q3	$206K	Hold	20,000	–	–	0.03%	171
2022 Q2	$200K	Hold	20,000	–	–	0.03%	180
2022 Q1	$246K	Hold	20,000	–	–	0.03%	177
2021 Q4	$347K	Hold	20,000	–	–	0.04%	164
2021 Q3	$359K	Hold	20,000	–	–	0.04%	152
2021 Q2	$457K	Hold	20,000	–	–	0.06%	133
2021 Q1	$299K	Sell	20,000 -50,000	-71%	-$546K	0.04%	158
2020 Q4	$378K	Hold	70,000	–	–	0.05%	133
2020 Q3	$319K	Hold	70,000	–	–	0.05%	148
2020 Q2	$344K	Hold	70,000	–	–	0.06%	133
2020 Q1	$221K	Hold	70,000	–	–	0.04%	168
2019 Q4	$181K	Hold	70,000	–	–	0.03%	205
2019 Q3	$221K	Hold	70,000	–	–	0.04%	176
2019 Q2	$236K	Hold	70,000	–	–	0.04%	176
2019 Q1	$214K	Hold	70,000	–	–	0.05%	167
2018 Q4	$109K	Hold	70,000	–	–	0.03%	180
2018 Q3	$191K	Hold	70,000	–	–	0.05%	167
2018 Q2	$183K	Hold	70,000	–	–	0.05%	163
2018 Q1	$193K	Hold	70,000	–	–	0.05%	155
2017 Q4	$225K	Hold	70,000	–	–	0.05%	153
2017 Q3	$290K	Buy	+70,000	New	+$311K	0.07%	135

Other funds holding AVXL

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

SNS Financial Group's AVXL Position: Q1 2024 in Review

SNS Financial Group sold out of Anavex Life Sciences (AVXL) in Q1 2024, closing a stake of 20,000 shares — an estimated $186K sold.

SNS Financial Group first reported a position in AVXL in Q3 2017 and held it in 26 quarters. The position peaked at $457K in Q2 2021. 147 funds tracked by Wall St. Rank hold AVXL as of Q1 2024.

SNS Financial Group reported no remaining Anavex Life Sciences position as of Q1 2024 after selling out during the quarter.
SNS Financial Group sold 20,000 Anavex Life Sciences shares in Q1 2024, an estimated $186K.
SNS Financial Group first reported a position in Anavex Life Sciences in Q3 2017 and held it in 26 quarters.
SNS Financial Group's Anavex Life Sciences position peaked at $457K in Q2 2021.
147 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2024.

Based on SNS Financial Group's 13F filing for Q1 2024, filed 24 Apr 2024.